FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2992463053> ?p ?o ?g. }

• W2992463053 endingPage "450" @default.
• W2992463053 startingPage "438" @default.
• W2992463053 abstract "Background:: Antifungal cyclic lipopeptides, bioactive metabolites produced by many species of the genus Bacillus, are promising alternatives to synthetic fungicides and antibiotics for the biocontrol of human pathogenic fungi. In a previous study, the co- production of five antifungal lipopeptides homologues (designated as AF1, AF2, AF3, AF4 and AF5) by the producer strain Bacillus subtilis RLID 12.1 using unoptimized medium was reported; though the two homologues AF3 and AF5 differed by 14 Da and in fatty acid chain length were found effective in antifungal action, the production/ yield rate of these two lipopeptides determined by High-Performance Liquid Chromatography was less in the unoptimized media. Methods:: In this study, the production/yield enhancement of the two compounds AF3 and AF5 was specifically targeted. Following the statistical optimization (Plackett-Burman and Box-Behnken designs) of media formulation, temperature and growth conditions, the production of AF3 and AF5 was improved by about 25.8- and 7.4-folds, respectively under static conditions. Results:: To boost the production of these two homologous lipopeptides in the optimized media, heat-inactivated Candida albicans cells were used as a supplement resulting in 34- and 14-fold increase of AF3 and AF5, respectively. Four clinical Candida auris isolates had AF3 and AF5 MICs (100 % inhibition) ranging between 4 and 16 μg/ml indicating the lipopeptide’s clinical potential. To determine the in vitro pharmacodynamic potential of AF3 and AF5, time-kill assays were conducted which showed that AF3 (at 4X and 8X concentrations) at 48h exhibited mean log reductions of 2.31 and 3.14 CFU/ml of C. albicans SC 5314, respectively whereas AF5 at 8X concentration showed a mean log reduction of 2.14 CFU/ml. Conclusion:: With the increasing threat of multidrug-resistant yeasts and fungi, these antifungal lipopeptides produced by optimized method promise to aid in the development of novel antifungal that targets disease-causing fungi with improved efficacy." @default.
• W2992463053 created "2019-12-13" @default.
• W2992463053 creator A5012247985 @default.
• W2992463053 creator A5024581417 @default.
• W2992463053 creator A5026887827 @default.
• W2992463053 creator A5031113461 @default.
• W2992463053 creator A5036831748 @default.
• W2992463053 creator A5068126372 @default.
• W2992463053 date "2020-04-29" @default.
• W2992463053 modified "2023-09-26" @default.
• W2992463053 title "Improved Production of Two Anti-<i>Candida</i> Lipopeptide Homologues Co- Produced by the Wild-Type <i>Bacillus subtilis</i> RLID 12.1 under Optimized Conditions" @default.
• W2992463053 cites W1730500298 @default.
• W2992463053 cites W1964834601 @default.
• W2992463053 cites W1967309281 @default.
• W2992463053 cites W1969503113 @default.
• W2992463053 cites W1973451490 @default.
• W2992463053 cites W1977146204 @default.
• W2992463053 cites W1979435687 @default.
• W2992463053 cites W1980410735 @default.
• W2992463053 cites W1987248968 @default.
• W2992463053 cites W1989778839 @default.
• W2992463053 cites W2006761936 @default.
• W2992463053 cites W2020505222 @default.
• W2992463053 cites W2021210228 @default.
• W2992463053 cites W2024949703 @default.
• W2992463053 cites W2029046024 @default.
• W2992463053 cites W2029769934 @default.
• W2992463053 cites W2030027217 @default.
• W2992463053 cites W2030910300 @default.
• W2992463053 cites W2041360850 @default.
• W2992463053 cites W2049669623 @default.
• W2992463053 cites W2065894938 @default.
• W2992463053 cites W2069555242 @default.
• W2992463053 cites W2072682511 @default.
• W2992463053 cites W2080189311 @default.
• W2992463053 cites W2094942535 @default.
• W2992463053 cites W2096930675 @default.
• W2992463053 cites W2108989058 @default.
• W2992463053 cites W2112115945 @default.
• W2992463053 cites W2119795301 @default.
• W2992463053 cites W2125848302 @default.
• W2992463053 cites W2128658496 @default.
• W2992463053 cites W2144832604 @default.
• W2992463053 cites W2153501732 @default.
• W2992463053 cites W2154137871 @default.
• W2992463053 cites W2157144917 @default.
• W2992463053 cites W2170764510 @default.
• W2992463053 cites W2345638602 @default.
• W2992463053 cites W2347104258 @default.
• W2992463053 cites W2414062728 @default.
• W2992463053 cites W2763413571 @default.
• W2992463053 cites W2765624775 @default.
• W2992463053 cites W2804053933 @default.
• W2992463053 cites W2884709303 @default.
• W2992463053 cites W4210968711 @default.
• W2992463053 cites W4250891871 @default.
• W2992463053 cites W42993733 @default.
• W2992463053 doi "https://doi.org/10.2174/1389201020666191205115008" @default.
• W2992463053 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31804165" @default.
• W2992463053 hasPublicationYear "2020" @default.
• W2992463053 type Work @default.
• W2992463053 sameAs 2992463053 @default.
• W2992463053 citedByCount "2" @default.
• W2992463053 countsByYear W29924630532022 @default.
• W2992463053 countsByYear W29924630532023 @default.
• W2992463053 crossrefType "journal-article" @default.
• W2992463053 hasAuthorship W2992463053A5012247985 @default.
• W2992463053 hasAuthorship W2992463053A5024581417 @default.
• W2992463053 hasAuthorship W2992463053A5026887827 @default.
• W2992463053 hasAuthorship W2992463053A5031113461 @default.
• W2992463053 hasAuthorship W2992463053A5036831748 @default.
• W2992463053 hasAuthorship W2992463053A5068126372 @default.
• W2992463053 hasConcept C2777272437 @default.
• W2992463053 hasConcept C2777425210 @default.
• W2992463053 hasConcept C2779548794 @default.
• W2992463053 hasConcept C2780917455 @default.
• W2992463053 hasConcept C523546767 @default.
• W2992463053 hasConcept C54355233 @default.
• W2992463053 hasConcept C71924100 @default.
• W2992463053 hasConcept C86803240 @default.
• W2992463053 hasConcept C89423630 @default.
• W2992463053 hasConceptScore W2992463053C2777272437 @default.
• W2992463053 hasConceptScore W2992463053C2777425210 @default.
• W2992463053 hasConceptScore W2992463053C2779548794 @default.
• W2992463053 hasConceptScore W2992463053C2780917455 @default.
• W2992463053 hasConceptScore W2992463053C523546767 @default.
• W2992463053 hasConceptScore W2992463053C54355233 @default.
• W2992463053 hasConceptScore W2992463053C71924100 @default.
• W2992463053 hasConceptScore W2992463053C86803240 @default.
• W2992463053 hasConceptScore W2992463053C89423630 @default.
• W2992463053 hasFunder F4320320717 @default.
• W2992463053 hasFunder F4320334771 @default.
• W2992463053 hasIssue "5" @default.
• W2992463053 hasLocation W29924630531 @default.
• W2992463053 hasLocation W29924630532 @default.
• W2992463053 hasOpenAccess W2992463053 @default.
• W2992463053 hasPrimaryLocation W29924630531 @default.
• W2992463053 hasRelatedWork W1749130010 @default.

• next